N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014871 |
| CAS No | NA |
| Mol.F. | C12H10N2O3 |
| Mol.Wt. | 230.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014872 |
| CAS No | NA |
| Mol.F. | C9H6N2O2 |
| Mol.Wt. | 174.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014873 |
| CAS No | NA |
| Mol.F. | C14H16N2O5 |
| Mol.Wt. | 292.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014874 |
| CAS No | NA |
| Mol.F. | C12H10N2O4 |
| Mol.Wt. | 246.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014875 |
| CAS No | NA |
| Mol.F. | C28H30ClN3O3 |
| Mol.Wt. | 492.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014876 |
| CAS No | NA |
| Mol.F. | C24H27N3O4 |
| Mol.Wt. | 421.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014877 |
| CAS No | 67776-06-1 |
| Mol.F. | C7H12N2O4S |
| Mol.Wt. | 220.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014878 |
| CAS No | NA |
| Mol.F. | C9H8N2O |
| Mol.Wt. | 160.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014879 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O3S |
| Mol.Wt. | 517.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014880 |
| CAS No | NA |
| Mol.F. | C18H19ClN8O2S |
| Mol.Wt. | 446.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014881 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N6O2S |
| Mol.Wt. | 423.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014882 |
| CAS No | 2135905-86-9 |
| Mol.F. | C20H21ClN8O2S |
| Mol.Wt. | 473.0 |
| INV STATUS | In Stock |
| CAT No | SRC-N014883 |
| CAS No | NA |
| Mol.F. | C20H21ClN8O2S |
| Mol.Wt. | 473.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014884 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014885 |
| CAS No | NA |
| Mol.F. | C25H29ClN8O4S |
| Mol.Wt. | 573.1 |
| INV STATUS | In Stock |
| CAT No | SRC-N014886 |
| CAS No | NA |
| Mol.F. | C25H42N2O19 |
| Mol.Wt. | 674.6 |
| INV STATUS | CUSTOM SYNTHESIS |